Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response

F. Sanz Herrero (València, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), M. García Clemente (Oviedo, Spain), P. España Yandiola (Galdakao, Spain), R. Guna Serrano (València, Spain), L. Serrano Fernández (Barakaldo, Spain), J. Herrero Huertas (Oviedo, Spain), A. Artaraz Ereño (Galdakao, Spain), N. Carrión Collado (València, Spain), E. Fernández Fabrellas (València, Spain)

Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Session: Lower respiratory tract infections in clinical practice
Session type: E-poster session
Number: 3091
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Sanz Herrero (València, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), M. García Clemente (Oviedo, Spain), P. España Yandiola (Galdakao, Spain), R. Guna Serrano (València, Spain), L. Serrano Fernández (Barakaldo, Spain), J. Herrero Huertas (Oviedo, Spain), A. Artaraz Ereño (Galdakao, Spain), N. Carrión Collado (València, Spain), E. Fernández Fabrellas (València, Spain). Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response. 3091

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007



Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




The impact of time on the systemic inflammatory response in pneumococcal pneumonia
Source: Eur Respir J 2010; 35: 614-618
Year: 2010



Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Performance of the binax NOW Streptococcus pneumoniae urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004

Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Source: Eur Respir J 2006; 27: 1010-1019
Year: 2006



Characteristics of patients with serotype 5 pneumococcal pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006

Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

The pathophysiology of pneumococcal pneumonia
Source: Eur Respir Monogr 2014; 63: 42-63
Year: 2014


Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008



Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Source: Eur Respir J 2011; 37: 147-153
Year: 2011



Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Absence of leukocytosis in bacteremic pneumococcal pneumonia
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009